<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 1; Issue 2, (Jul-Dec,2021)</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>Archives of Medical and Clinical Research</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical and Clinical Research</ArticleType>
      <ArticleTitle>Robust and Well-Designed Studies are Needed to Clarify Whether COVID-19 Vaccines can Interfere with Coagulation</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>2</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Fazio</FirstName>
          <LastName>S</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Affuso</FirstName>
          <LastName>F</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract/>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>COVID-19,Vaccines,Coagulation,SARS-COV-2,D-dimer</Keywords>
      <URLs>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=15238&amp;title=Robust and Well-Designed Studies are Needed to Clarify Whether COVID-19 Vaccines can Interfere with Coagulation</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Association of American Physicians and Surgeons. Blood clotting needs to be watched with all COVID vaccines, states the Association of American Physicians and Surgeons (AAPS). April 05,2021. CISION, PR New’swire.&#13;
&#13;
Favaloro EJ. Laboratory testing for suspected COVID-19 Vaccine-Induced (immune) thrombotic thrombocytopenia. Int J Lab Hematol 2021; 43: 559-570.&#13;
&#13;
Iba T, Levy JH, Levi M, Connors JM, Thachil J. Coagulopathy of coronavirus disease 2019. Crit Care Med 2020; 48: 1358-1364.&#13;
&#13;
Liu J, Wang J, Xu J, Xia H, Wang Y, Zhang C, Chen W, Zhang H, Liu Q, Zhu R, Shi Y. Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell Discov 2021; 7: 99.&#13;
&#13;
Lundstrom K, Barh D, Uhal BD, Takayama K, Aljabali AA, El-Aziz A, Mohamed T, Lal A, Redwan EM, Adadi P, Chauhan G. COVID-19 vaccines and thrombosis-roadblock or dead-end street? Biomolecules 2021; 11:1020.&#13;
&#13;
Shutte T, Thijs A, Smulders YM. Never ignore extremely elevated D-dimer levels: they are specific for serious illness. Neth J Med 2016; 74: 443-448.&#13;
&#13;
Weitz JI, Fredenburg JC, Eikelboom JW. A text in Context: D-dimer. J Am Coll Cardiol 2017; 70: 2411-2420.&#13;
&#13;
Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, Liu M, Zhao X, Xie Y, Yang Y, Zhang S. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol 2020; 13: 120.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>